CEVA Animal Health Launches Meloxidyl® Injection

CEVA Animal Health has added to its comprehensive joint care range with the launch of Meloxidyl® Injection to help control post-operative pain in cats and dogs and alleviate musculoskeletal pain in dogs. Meloxidyl® Injection is bioequivalent to the leading meloxicam injection and dogs can be given Meloxidyl® oral suspension 24 hours after Meloxidyl® Injection has been administered. Complementing CEVA Animal Health`s joint care range, which includes Meloxidyl® oral suspension, Carprodyl® F and Flexivet® Plus, Meloxidyl® Injection is cost-effective for both veterinary practices and clients and is available in 10ml bottles containing 5mg/ml of meloxicam. For further information, please contact your CEVA Animal Health representative or call 01494 781510.

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards